Back to Search
Start Over
Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis
- Source :
- JACC. Cardiovascular interventions. 7(8)
- Publication Year :
- 2013
-
Abstract
- The aim of this study was to compare transfemoral transcatheter aortic valve replacement (TF TAVR) performed in a catheterization laboratory (minimalist approach [MA]) with TF TAVR performed in a hybrid operating room (standard approach [SA]).A MA-TF TAVR can be performed without general anesthesia, transesophageal echocardiography, or a surgical hybrid room. The outcomes and cost of MA-TF TAVR compared with those of the SA have not been described.Patients who underwent elective, percutaneous TF TAVR using the Edwards Sapien valve (Edwards Lifesciences, Irvine, California) were studied. Baseline characteristics, outcomes, and hospital costs of MA-TF TAVR and SA-TF TAVR were compared.A total of 142 patients were studied (MA-TF TAVR, n = 70 and SA-TF TAVR, n = 72). There were no differences in baseline comorbidities (Society of Thoracic Surgeons score, 10.6 ± 4.3 vs. 11.4 ± 5.8; p = 0.35). All procedures in the MA-TF TAVR group were successful; 1 patient was intubated. Three patients in the SA-TF TAVR group had procedure-related death. Procedure room time (150 ± 48 min vs. 218 ± 56 min, p0.001), total intensive care unit time (22 h vs. 28 h, p0.001), length of stay from procedure to discharge (3 days vs. 5 days, p0.001), and cost ($45,485 ± 14,397 vs. $55,377 ± 22,587, p0.001) were significantly less in the MA-TF TAVR group. Mortality at 30 days was not significantly different in the MA-TF TAVR group (0 vs. 6%, p = 0.12) and 30-day stroke/transient ischemic attack was similar (4.3% vs. 1.4%, p = 0.35). Moderate or severe paravalvular leak and device success were similar in the MA-TF TAVR and SA-TF TAVR groups (3% vs. 5.8%, p = 0.4 and 90% vs. 88%, p = 0.79, respectively) at 30 days. At a median follow-up of 435 days, there was no significant difference in survival (MA-TF TAVR, 83% vs. SA-TF TAVR, 82%; p = 0.639).MA-TF TAVR can be performed with minimal morbidity and mortality and equivalent effectiveness compared with SA-TF TAVR. The shorter length of stay and lower resource use with MA-TF TAVR significantly lowers hospital costs.
- Subjects :
- Aged, 80 and over
Heart Valve Prosthesis Implantation
Male
Cardiac Catheterization
Operating Rooms
Georgia
Time Factors
Cost-Benefit Analysis
Process Assessment, Health Care
Aortic Valve Stenosis
Anesthesia, General
Length of Stay
Prosthesis Design
Femoral Artery
Intensive Care Units
Treatment Outcome
Cost Savings
Risk Factors
Heart Valve Prosthesis
Humans
Female
Hospital Costs
Echocardiography, Transesophageal
Aged
Retrospective Studies
Subjects
Details
- ISSN :
- 18767605
- Volume :
- 7
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- JACC. Cardiovascular interventions
- Accession number :
- edsair.pmid..........a9b687e8126391cf6a9df612258809bb